CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

本分项目是CTSA供资的估计百分比，即 被用于广泛的研究领域(艾滋病研究、儿科研究或 临床试验)。列出的总成本仅是对CTSA金额的估计 用于这一研究领域的基础设施，而不是由 授予子项目或子项目工作人员的NCRR补助金。 堪萨斯大学哈特兰临床与翻译研究所(HICTR)成立于2007年，以响应国家CTSA倡议。HICTR的愿景是通过创建一个从长凳到床边再到社区的新颖和变革性的翻译研究企业来改善堪萨斯州的健康。我们HICTR项目的特别优势是一个创业性的药物和设备发现和开发计划，以及一个发展良好和高度成功的基于社区的研究计划。HICTR的具体目标是：1)创建一个新的学术之家，为临床和翻译研究人员提供创新的培训计划；2)提供增强的协调翻译研究基础设施；以及3)通过利用和扩大现有网络，积极让社区参与开发、测试和传播研究，以改善所有堪萨斯州人的健康，特别是农村、服务不足和其他目标社区的健康。HICTR拟议的基础设施和教育计划将通过增强和整合现有资源以便于访问，开发新的创新资源，并利用驻留在大学内研究中心的资源[包括我们的KINBRE和五个Cobre补助金~]和我们的HICTR网络机构，来应对临床和转化型研究人员面临的挑战。为了支持我们的目标，我们在规划、发展和建立卢旺达问题国际法庭方面调动了一系列令人印象深刻的机构、公司和社区资源。卢旺达问题国际法庭将提供新的基础设施以及培训和教育计划，以支持研究人员的临床和转化性研究，即将实验室发现带入人类首次试验(TL研究)，并将研究转移到研究成果的传播和实施的研究(T2研究)。在非同寻常的机构和社区支持下，我们已经取得了巨大的进步。来自CTSA计划的资金将使堪萨斯大学的HICTR有机会充分发挥其潜力，不仅为我们地区，而且还为国家CTSA协会做出贡献。RELEVANCE(参见说明)：堪萨斯大学心脏地带临床和翻译研究所是临床和翻译研究的学术之家，为科学家提供支持，并让社区参与，以便与L一起的发现和研究结果更快地被带到护理点，从而改善所有堪萨斯州人的健康。

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. The University of Kansas Heartland Institute for Clinical and Translational Research (HICTR) was established in 2007 in response to the national CTSA initiative. The vision of the HICTR is to improve the health of Kansans by creating a novel and transformative translational research enterprise from bench to bedside to community. Particular strengths of our HICTR program are an entrepreneurial drug and device discovery and development program and a well-developed and highly accomplished community-based research program. The specific aims of the HICTR are to: 1) create a new academic home with innovative training programs for clinical and translational Investigators; 2) provide an enhanced coordinated translational research infrastructure; and 3) actively engage the community in developing, testing, and disseminating research, by capitalizing on and expanding existing networks, to improve the health of all Kansans¿especially those in rural, underserved and other target communities. The proposed infrastructure and educational programs of the HICTR will address the challenges facing clinical and translational investigators by enhancing and integrating existing resources for easier access, developing new innovative resources, and capitalizing on resources residing in research centers across the university¿including our KINBRE and five COBRE grants~and our HICTR network institutions. In support of our aims, we have marshaled an impressive array of institutional, corporate, and community resources in planning, developing, and establishing the HICTR. The HICTR will provide new infrastructure and training and educational programs to support investigators' clinical and translational research¿taking laboratory discoveries to first trials in humans (Tl research) and moving research through to studies on dissemination and implementation of research findings to practice (T2 research). With extraordinary institutional and community support, we already have made tremendous progress. Funding from the CTSA program will allow the University of Kansas' HICTR the opportunity to fully realize its potential not only for our region, but also to contribute to the national CTSA Consortium.RELEVANCE (See Instructions): The University of Kansas Heartland Institute for Clinical and Translational Research is an academic home for clinical and translational research, providing support to scientists and involving the community, so that discoveries and research findings wi|l be brought more rapidly to the point of care, thus improving the health of all Kansans.